Surveillance of SARS-CoV-2 in nine neighborhood sewersheds in Detroit Tri-County area, United States: Assessing per capita SARS-CoV-2 estimations and COVID-19 incidenceResearch article Published on 2022-12-012022-10-05 Journal: The Science of the total environment [Category] COVID19(2023년), SARS, 바이오마커, 치료기술, [키워드] 5-hydroxyindoleacetic acid acute respiratory syndrome Assessing Biomarker Biomarkers collected Community Comparisons Concentration coronavirus correlation COVID-19 COVID-19 burdens COVID-19 case COVID-19 incidence creatinine cumulative demographic characteristics demographics Detroit Detroit Tri-County area Epidemiology genomic indicate Infection N1 and N2 nine normalized parameter polymerase chain Population predict quantified reduced RNA concentration SARS-CoV-2 SARS-CoV-2 RNA normalization screened selected suggested the disease transcriptase wastewater Wastewater-based epidemiology with COVID-19 xanthine [DOI] 10.1016/j.scitotenv.2022.158350 [Article Type] Research article
COVID-19 and the injured patient: A multicenter reviewResearch article Published on 2022-12-012022-10-05 Journal: The Journal of surgical research [Category] 바이오마커, [키워드] adverse events Affect age Analysis baseline characteristics C-reactive protein Coagulopathy Cohort collected Comorbidities composed Coronavirus disease 2019 COVID-19 cumulative D-dimer demographics diabetes events ferritin Frame Hospitalization hypertension In-hospital death Injury ISS Kaplan–Meier method log-rank test median morbidity and mortality Mortality multicenter neurologic New York Older outcome outcomes Patient patients performed physiological Primary outcome Result Retrospective analysis severity shown study period surgical tested trauma trauma patient trauma patients were excluded were used [DOI] 10.1016/j.jss.2022.06.068 [Article Type] Research article
Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trialArticle Published on 2022-11-082022-11-16 Journal: Trials [Category] SARS, 변종, [키워드] adaptive anti-COVID-19 IVIG antivirals clinical evidence clinical trial collected convalescent convalescent plasma COVID-19 cumulative death Efficacy eligibility criteria evaluate Health hyperimmune immunization immunomodulators intravenous Intravenous immunoglobulin low dose monoclonal antibodies Neutralizing non-specific novel Novel coronavirus outcome Passive passive immunization Patient phase Pneumonia polyclonal polyclonal antibodies Pooled convalescent plasma Potential treatment Randomized Randomized controlled trial receive Recovered COVID-19 patients reported SARS CoV-2 SARS CoV-2. SARS-CoV-2 sealed Secondary outcomes severe COVID-19 severe COVID-19 patient severe COVID-19 patients Standard of care Steroids Study protocol therapeutic option therapy treat Treatment Trial variant variants of concern virus virus particles World Health Organization [DOI] 10.1186/s13063-022-06860-2 PMC 바로가기
The variant-specific burden of SARS-CoV-2 in Michigan: March 2020 through November 2021Article Published on 2022-11-012022-11-16 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] accounting acute respiratory syndrome Adjustment age available data case fatality children coronavirus Coronavirus disease 2019 COVID-19 cumulative death died dose estimate estimates Factor highlight Hospitalization hospitalizations Hospitalized incidence Infection measure pandemic proportion reached reported risk SARS-CoV-2 seroprevalence. Surveillance System under-detection vaccination variant widespread [DOI] 10.1002/jmv.27982 PMC 바로가기
Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021Article Published on 2022-11-012022-11-15 Journal: Influenza and Other Respiratory Viruses [Category] COVID19(2023년), SARS, 진단, [키워드] absence age Anti-nucleocapsid antibodies antibody automatically children collected conducted confirmed COVID-19 case contributed COVID-19 COVID-19 case COVID-19 pandemic COVID-19 vaccination CrI cross-sectional cumulative estimate Estimated flow cytometric IgG antibody individual Infection Laboratory National Norway nucleocapsid nucleocapsid protein Prevalence RBD Receptor binding domain registry data residual SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 seroprevalence sera seropositive sample Seroprevalence the spike protein vaccination vaccination. were measured women [DOI] 10.1111/irv.13024 PMC 바로가기
Atezolizumab for the treatment of advanced recurrent basal cell carcinoma and urothelial carcinoma of bladder: a case reportArticle Published on 2022-10-312022-11-15 Journal: Journal of Medical Case Reports [Category] 진단, [키워드] Administered Advanced basal cell carcinoma atezolizumab bladder Bladder cancer Cancer cancers carried Case report Cell Checkpoint inhibitor chemotherapeutic agent clinician Comorbidity Complete Compliance complication of COVID-19 cumulative Definitive disease dose female histology hospital increasingly indicated Infection inhibitor knowledge lymph nodes Metastasis metastatic Metastatic muscle-invasive bladder cancer Patient PD-L1 PD-L1 inhibitor. positive progressed Radiotherapy reached receiving Side effects smoking synchronous the patient therapy transurethral resection treated Treatment tumors [DOI] 10.1186/s13256-022-03634-x PMC 바로가기
Integrative analyses of genes about venous thromboembolism: An umbrella review of systematic reviews and meta-analysesArticle Published on 2022-10-282022-11-16 Journal: Medicine [Category] meta-analysis, 변종, [키워드] activating analysis Analysis appraisal checklist conducted COVID-19 vaccination criteria Critical cumulative database Effect effect size eligible endothelial environmental risk factor Epidemiology estimates etiology Evidence Genetic genetic risk factor Genetic variant Genetic variations had more heterogeneity Human identify Intervention meta-analyses meta-analysis MTHFR network p values performed polymorphism protease Protein prothrombin provided receptor respond review risk Risk factors Sample size selected surgical systematic review variable variant Venice venous Venous Thromboembolism VTE was performed were used [DOI] 10.1097/MD.0000000000031162 PMC 바로가기
Influenza Incidence and Vaccine Effectiveness During the Southern Hemisphere Influenza Season – Chile, 2022Article Published on 2022-10-282022-11-15 Journal: Morbidity and Mortality Weekly Report [Category] COVID19(2023년), SARS, 치료기술, [키워드] absence affected Atypical benefit clade close contact Community country COVID-19 pandemic COVID-19 vaccine cumulative Effectiveness eligible Epidemics Face mask Hemisphere Hospitalization incidence include Influenza influenza infection Influenza virus measure Measures pandemic partner physical distancing Pneumonia Precaution reduce SARS-CoV-2 season severe disease southern hemisphere the United State Transmission vaccination Vaccine virus [DOI] 10.15585/mmwr.mm7143a1 PMC 바로가기
Epidemiological measures for assessing the dynamics of the SARS-CoV-2-outbreak: Simulation study about bias by incomplete case-detectionArticle Published on 2022-10-262022-11-15 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 치료기술, [키워드] applied Comparisons Course cumulative doubling effective Epidemics epidemiological hypothetical incidence rates Intervention lockdown measure Measures outbreak Reproduction number resulting SARS-CoV-2 Simulation the epidemic the SARS-CoV-2 Variation [DOI] 10.1371/journal.pone.0276311 PMC 바로가기
Effects of Wearing FFP2 Masks on SARS-CoV-2 Infection Rates in ClassroomsArticle Published on 2022-10-192022-11-16 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), SARS, 치료기술, [키워드] appear children classroom COVID-19 cumulative Delta Effect FFP2 incidence infected with SARS-CoV-2 Infection infection with SARS-CoV-2 infections likelihood mandatory many cases Mask Masks Measures observation period omicron Rate reduced retrospective cohort study SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 transmission School significantly higher Transmission Transmission. wearing [DOI] 10.3390/ijerph192013511 PMC 바로가기